MRNA
Moderna Inc.
$55.11
▲ +0.53%
+$0.29
NASDAQ · Healthcare · Biotechnology
· price updated 9h ago
Moderna Inc.
MRNA · NASDAQ · Healthcare · Biotechnology · price updated 9h ago
$55.11
▲ +0.53% · +$0.29 today
AI research · $55.11
Track MRNA for continuous AI research
price position
Where MRNA sits now
52-week range
Low$22.28
High$85.60
Today $55.11
RSI (14)
13.7Oversold
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$5.1B
Total debt$1.2B
Net cash after debt$3.9B
Valuation
What the market charges
Forward P/E
Price against expected earnings
No signal · Not enough data to judge
-
Price / sales
Value assigned to each sales dollar
Rich · Above 8x annual sales
9.82x
Price / FCF
Price against free cash generation
No signal · Not enough data to judge
-
EV / EBITDA
Operating value including debt
No signal · Not enough data to judge
-
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
-76.0%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-39.0%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.19x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.29x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How MRNA compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $21.75B | - | -27.6% | 47 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Moderna Inc. (MRNA) stock
Moderna Inc. tracked in the US core universe. MRNA was +0.5% in the latest available session at $55.11. Its reported market value was $21.75B with a trailing P/E of 0.0. Latest reported revenue was $2.23B, changing -27.6% year over year, with $-3.15B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $55.11
- Day change
- +0.5%
- Market cap
- $21.75B
- P/E (TTM)
- 0.0
- Revenue growth
- -27.6%
- Industry
- Biotechnology